Allograft rejection, acute and chronic, is a common complication of organ transplantation, significantly Increases medical costs, but more Importantly It dramatically and negatively affects the lives of patients. In the previous grant period we have carried out a large-scale mass spectrometry-based proteomic analysis in clinical samples from patients undergoing acute and the chronic kidney transplant rejection and compared these to patients with healthy transplants. We have studied biopsies and peripheral blood Including purified, activated T and B cells. We have identified 1,000s of proteins differentially expressed among the patient cohorts with various clinical outcomes. Many of these proteins belong to key cellular, innate immunity, inflammatory and tissue remodeling pathways and are very likely the first proteomic signatures of rejection. We propose to continue our work with transplant proteomics and to extend our studies Into the areas of clinical proteomic assay development, heart transplant rejection, and human lymphocyte phosphoproteomlcs.
In Specific Aim #1 we are proposing to develop a diagnostic, high-throughput clinical proteomic blood-based assay for acute and chronic rejection based on selected reaction monitoring (SRM) targeted mass spectrometry. The large-scale discovery efforts from the previous grant period yielded many potential targets for candidate biomarkers that will be validated via SRM and developed into a diagnostic assay.
In Specific Aim #2 we are going to perform large-scale discovery-based mass spectrometry proteomic analysis of acute and chronic heart transplant rejection. We hope to unravel some of the molecular mechanisms and biological functions that are indicative of heart transplant rejection by further comparing our new data to the proteomic data from the kidney transplant system.
Specific Aim #3 is geared toward the phosphoproteomic analysis of transplant rejection. We are proposing to Identify and quantify proteins that become phosphorylated as a response to transplant rejection. We will profile the CD4 T and B cells from patients undergoing transplant rejection and Investigate signaling changes taking place due to the transplant related Immunosuppression, T and B cell activation and Inflammatory processes.

Public Health Relevance

The work proposed In this grant Involves the following novel approaches In mass spectrometry-based proteomics applied to a clinical study. First, we propose to develop the first blood-based proteomic assay for acute and chronic kidney transplant rejection using SRM. We plan a comprehensive study of protein expression post heart transplantation from both transplant biopsies and peripheral blood. We will investigate the driving forces behind transplant rejection and test the hypothesis that there are common, unifying mechanisms of rejection for both heart and kidney transplants. Finally, we plan to perform a novel discovery study into phosphorylation events that drive cell-mediated immune responses and the efficacy of immunosuppression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI063603-11
Application #
8718976
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
11
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Leventhal, J R; Mathew, J M; Salomon, D R et al. (2016) Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers. Am J Transplant 16:221-34
LaMere, S A; Thompson, R C; Komori, H K et al. (2016) Promoter H3K4 methylation dynamically reinforces activation-induced pathways in human CD4 T cells. Genes Immun 17:283-97
Modena, B D; Milam, R; Harrison, F et al. (2016) Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. Am J Transplant :
Savaryn, John P; Toby, Timothy K; Catherman, Adam D et al. (2016) Comparative top down proteomics of peripheral blood mononuclear cells from kidney transplant recipients with normal kidney biopsies or acute rejection. Proteomics 16:2048-58
Weinsheimer, Shantel; Bendjilali, Nasrine; Nelson, Jeffrey et al. (2016) Genome-wide association study of sporadic brain arteriovenous malformations. J Neurol Neurosurg Psychiatry 87:916-23
Kurian, S M; Fouraschen, S M G; Langfelder, P et al. (2015) Genomic profiles and predictors of early allograft dysfunction after human liver transplantation. Am J Transplant 15:1605-14
Norden-Krichmar, Trina M; Gizer, Ian R; Phillips, Evelyn et al. (2015) Variants Near CCK Receptors are Associated With Electrophysiological Responses to Pre-pulse Startle Stimuli in a Mexican American Cohort. Twin Res Hum Genet 18:727-37
Magdeldin, Sameh; Blaser, Rachel E; Yamamoto, Tadashi et al. (2015) Behavioral and proteomic analysis of stress response in zebrafish (Danio rerio). J Proteome Res 14:943-52
Komori, H Kiyomi; Hart, Traver; LaMere, Sarah A et al. (2015) Defining CD4 T cell memory by the epigenetic landscape of CpG DNA methylation. J Immunol 194:1565-79
Routh, Andrew; Head, Steven R; Ordoukhanian, Phillip et al. (2015) ClickSeq: Fragmentation-Free Next-Generation Sequencing via Click Ligation of Adaptors to Stochastically Terminated 3'-Azido cDNAs. J Mol Biol 427:2610-6

Showing the most recent 10 out of 66 publications